Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction

Yutaka Matsui, Masahiro Ikesue, Keiko Danzaki, Junko Morimoto, Mami Sato, Shinya Tanaka, Tetsuhito Kojima, Hiroyuki Tsutsui, Toshimitsu Uede

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Rationale: Syndecan-4 (Syn4), a cell-surface heparan sulfate proteoglycan, has been detected in the infarct region after myocardial infarction (MI), but its functional significance has not been elucidated. Objective: We examined whether and how Syn4 regulates the cardiac healing process after MI. Methods and results: Although the heart in Syn4-deficient (Syn4) mice was morphologically and functionally normal, Syn4 mice exhibited impaired heart function and increased mortality rate as a result of cardiac ruptures after MI. Cardiac ruptures in Syn4 mice were associated with reduced inflammatory reaction and impaired granulation tissue formation during the early phase of MI, as evidenced by reduced numbers of leukocytes, fibroblasts, myofibroblasts, macrophages, and capillary vessels, along with reduced extracellular matrix protein deposition in the infarct region after MI. Transforming growth factor-β1-dependent cell signaling was preserved, whereas cell migration, fibronectin-induced cell signaling, and differentiation into myofibroblasts were defective in Syn4 cardiac fibroblasts. We also found that Syn4 was involved in basic fibroblast growth factor-dependent endothelial cell signaling, cell proliferation, and tube formation. Finally, overexpression of the shed form of Syn4 before MI creation led to an increase in mortality due to cardiac rupture via its action as a dominant-negative inhibitor of endogenous Syn4 signaling, which suggested a protective role of Syn4 signaling in MI. Conclusions: These results suggest that Syn4 plays an important role in the inflammatory response and granulation tissue formation, thereby preventing cardiac rupture and dysfunction after MI.

Original languageEnglish
Pages (from-to)1328-1339
Number of pages12
JournalCirculation research
Volume108
Issue number11
DOIs
Publication statusPublished - May 27 2011
Externally publishedYes

Fingerprint

Syndecan-4
Heart Rupture
Myocardial Infarction
Myofibroblasts
Granulation Tissue
Fibroblasts
Heparan Sulfate Proteoglycans
Mortality
Extracellular Matrix Proteins
Transforming Growth Factors
Fibroblast Growth Factor 2
Leukocyte Count
Fibronectins

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Matsui, Y., Ikesue, M., Danzaki, K., Morimoto, J., Sato, M., Tanaka, S., ... Uede, T. (2011). Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. Circulation research, 108(11), 1328-1339. https://doi.org/10.1161/CIRCRESAHA.110.235689

Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. / Matsui, Yutaka; Ikesue, Masahiro; Danzaki, Keiko; Morimoto, Junko; Sato, Mami; Tanaka, Shinya; Kojima, Tetsuhito; Tsutsui, Hiroyuki; Uede, Toshimitsu.

In: Circulation research, Vol. 108, No. 11, 27.05.2011, p. 1328-1339.

Research output: Contribution to journalArticle

Matsui, Y, Ikesue, M, Danzaki, K, Morimoto, J, Sato, M, Tanaka, S, Kojima, T, Tsutsui, H & Uede, T 2011, 'Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction', Circulation research, vol. 108, no. 11, pp. 1328-1339. https://doi.org/10.1161/CIRCRESAHA.110.235689
Matsui Y, Ikesue M, Danzaki K, Morimoto J, Sato M, Tanaka S et al. Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. Circulation research. 2011 May 27;108(11):1328-1339. https://doi.org/10.1161/CIRCRESAHA.110.235689
Matsui, Yutaka ; Ikesue, Masahiro ; Danzaki, Keiko ; Morimoto, Junko ; Sato, Mami ; Tanaka, Shinya ; Kojima, Tetsuhito ; Tsutsui, Hiroyuki ; Uede, Toshimitsu. / Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. In: Circulation research. 2011 ; Vol. 108, No. 11. pp. 1328-1339.
@article{8e49b9b7879445dc8ae6ccdf5b891d78,
title = "Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction",
abstract = "Rationale: Syndecan-4 (Syn4), a cell-surface heparan sulfate proteoglycan, has been detected in the infarct region after myocardial infarction (MI), but its functional significance has not been elucidated. Objective: We examined whether and how Syn4 regulates the cardiac healing process after MI. Methods and results: Although the heart in Syn4-deficient (Syn4) mice was morphologically and functionally normal, Syn4 mice exhibited impaired heart function and increased mortality rate as a result of cardiac ruptures after MI. Cardiac ruptures in Syn4 mice were associated with reduced inflammatory reaction and impaired granulation tissue formation during the early phase of MI, as evidenced by reduced numbers of leukocytes, fibroblasts, myofibroblasts, macrophages, and capillary vessels, along with reduced extracellular matrix protein deposition in the infarct region after MI. Transforming growth factor-β1-dependent cell signaling was preserved, whereas cell migration, fibronectin-induced cell signaling, and differentiation into myofibroblasts were defective in Syn4 cardiac fibroblasts. We also found that Syn4 was involved in basic fibroblast growth factor-dependent endothelial cell signaling, cell proliferation, and tube formation. Finally, overexpression of the shed form of Syn4 before MI creation led to an increase in mortality due to cardiac rupture via its action as a dominant-negative inhibitor of endogenous Syn4 signaling, which suggested a protective role of Syn4 signaling in MI. Conclusions: These results suggest that Syn4 plays an important role in the inflammatory response and granulation tissue formation, thereby preventing cardiac rupture and dysfunction after MI.",
author = "Yutaka Matsui and Masahiro Ikesue and Keiko Danzaki and Junko Morimoto and Mami Sato and Shinya Tanaka and Tetsuhito Kojima and Hiroyuki Tsutsui and Toshimitsu Uede",
year = "2011",
month = "5",
day = "27",
doi = "10.1161/CIRCRESAHA.110.235689",
language = "English",
volume = "108",
pages = "1328--1339",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction

AU - Matsui, Yutaka

AU - Ikesue, Masahiro

AU - Danzaki, Keiko

AU - Morimoto, Junko

AU - Sato, Mami

AU - Tanaka, Shinya

AU - Kojima, Tetsuhito

AU - Tsutsui, Hiroyuki

AU - Uede, Toshimitsu

PY - 2011/5/27

Y1 - 2011/5/27

N2 - Rationale: Syndecan-4 (Syn4), a cell-surface heparan sulfate proteoglycan, has been detected in the infarct region after myocardial infarction (MI), but its functional significance has not been elucidated. Objective: We examined whether and how Syn4 regulates the cardiac healing process after MI. Methods and results: Although the heart in Syn4-deficient (Syn4) mice was morphologically and functionally normal, Syn4 mice exhibited impaired heart function and increased mortality rate as a result of cardiac ruptures after MI. Cardiac ruptures in Syn4 mice were associated with reduced inflammatory reaction and impaired granulation tissue formation during the early phase of MI, as evidenced by reduced numbers of leukocytes, fibroblasts, myofibroblasts, macrophages, and capillary vessels, along with reduced extracellular matrix protein deposition in the infarct region after MI. Transforming growth factor-β1-dependent cell signaling was preserved, whereas cell migration, fibronectin-induced cell signaling, and differentiation into myofibroblasts were defective in Syn4 cardiac fibroblasts. We also found that Syn4 was involved in basic fibroblast growth factor-dependent endothelial cell signaling, cell proliferation, and tube formation. Finally, overexpression of the shed form of Syn4 before MI creation led to an increase in mortality due to cardiac rupture via its action as a dominant-negative inhibitor of endogenous Syn4 signaling, which suggested a protective role of Syn4 signaling in MI. Conclusions: These results suggest that Syn4 plays an important role in the inflammatory response and granulation tissue formation, thereby preventing cardiac rupture and dysfunction after MI.

AB - Rationale: Syndecan-4 (Syn4), a cell-surface heparan sulfate proteoglycan, has been detected in the infarct region after myocardial infarction (MI), but its functional significance has not been elucidated. Objective: We examined whether and how Syn4 regulates the cardiac healing process after MI. Methods and results: Although the heart in Syn4-deficient (Syn4) mice was morphologically and functionally normal, Syn4 mice exhibited impaired heart function and increased mortality rate as a result of cardiac ruptures after MI. Cardiac ruptures in Syn4 mice were associated with reduced inflammatory reaction and impaired granulation tissue formation during the early phase of MI, as evidenced by reduced numbers of leukocytes, fibroblasts, myofibroblasts, macrophages, and capillary vessels, along with reduced extracellular matrix protein deposition in the infarct region after MI. Transforming growth factor-β1-dependent cell signaling was preserved, whereas cell migration, fibronectin-induced cell signaling, and differentiation into myofibroblasts were defective in Syn4 cardiac fibroblasts. We also found that Syn4 was involved in basic fibroblast growth factor-dependent endothelial cell signaling, cell proliferation, and tube formation. Finally, overexpression of the shed form of Syn4 before MI creation led to an increase in mortality due to cardiac rupture via its action as a dominant-negative inhibitor of endogenous Syn4 signaling, which suggested a protective role of Syn4 signaling in MI. Conclusions: These results suggest that Syn4 plays an important role in the inflammatory response and granulation tissue formation, thereby preventing cardiac rupture and dysfunction after MI.

UR - http://www.scopus.com/inward/record.url?scp=79958150282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958150282&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.110.235689

DO - 10.1161/CIRCRESAHA.110.235689

M3 - Article

C2 - 21493899

AN - SCOPUS:79958150282

VL - 108

SP - 1328

EP - 1339

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 11

ER -